Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

Standard

Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting). / Bruno, Benedetto; Auner, Holger W; Gahrton, Gösta; Garderet, Laurent; Festuccia, Moreno; Ladetto, Marco; Lemoli, Roberto M; Massaia, Massimo; Morris, Curly; Palumbo, Antonio; Schönland, Stefan; Boccadoro, Mario; Kröger, Nicolaus.

In: LEUKEMIA LYMPHOMA, Vol. 57, No. 6, 06.01.2016, p. 1256-1268.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Bruno, B, Auner, HW, Gahrton, G, Garderet, L, Festuccia, M, Ladetto, M, Lemoli, RM, Massaia, M, Morris, C, Palumbo, A, Schönland, S, Boccadoro, M & Kröger, N 2016, 'Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)', LEUKEMIA LYMPHOMA, vol. 57, no. 6, pp. 1256-1268. https://doi.org/10.3109/10428194.2015.1131278

APA

Bruno, B., Auner, H. W., Gahrton, G., Garderet, L., Festuccia, M., Ladetto, M., Lemoli, R. M., Massaia, M., Morris, C., Palumbo, A., Schönland, S., Boccadoro, M., & Kröger, N. (2016). Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting). LEUKEMIA LYMPHOMA, 57(6), 1256-1268. https://doi.org/10.3109/10428194.2015.1131278

Vancouver

Bibtex

@article{b81b1b3a38714e279855e6b1fbc20eae,
title = "Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)",
abstract = "The European Society for Blood and Marrow Transplantation Chronic Malignancies Working Party held a preceptorship meeting in Turin, Italy on 25-26 September 2014, to discuss the role of stem cell transplantation (SCT) in the treatment of multiple myeloma and other plasma cell disorders. Scientists and clinicians working in the field gathered to discuss a variety of topics including the results of recent clinical trials, basic research, the concept of minimal residual disease, and immune modulation. As individual presentations revealed, important advances have occurred in our understanding of the pathophysiology of myeloma and the role that SCT, along with other forms of immunotherapy, plays in treating it. Each presentation stimulated discussion and exchange of ideas among the attendants. We decided to summarize and, importantly, to update the meeting proceedings in this review to share stimulating discussions and ideas on potentially novel treatment strategies among clinicians.",
author = "Benedetto Bruno and Auner, {Holger W} and G{\"o}sta Gahrton and Laurent Garderet and Moreno Festuccia and Marco Ladetto and Lemoli, {Roberto M} and Massimo Massaia and Curly Morris and Antonio Palumbo and Stefan Sch{\"o}nland and Mario Boccadoro and Nicolaus Kr{\"o}ger",
year = "2016",
month = jan,
day = "6",
doi = "10.3109/10428194.2015.1131278",
language = "English",
volume = "57",
pages = "1256--1268",
journal = "LEUKEMIA LYMPHOMA",
issn = "1042-8194",
publisher = "informa healthcare",
number = "6",

}

RIS

TY - JOUR

T1 - Stem cell transplantation in multiple myeloma and other plasma cell disorders (report from an EBMT preceptorship meeting)

AU - Bruno, Benedetto

AU - Auner, Holger W

AU - Gahrton, Gösta

AU - Garderet, Laurent

AU - Festuccia, Moreno

AU - Ladetto, Marco

AU - Lemoli, Roberto M

AU - Massaia, Massimo

AU - Morris, Curly

AU - Palumbo, Antonio

AU - Schönland, Stefan

AU - Boccadoro, Mario

AU - Kröger, Nicolaus

PY - 2016/1/6

Y1 - 2016/1/6

N2 - The European Society for Blood and Marrow Transplantation Chronic Malignancies Working Party held a preceptorship meeting in Turin, Italy on 25-26 September 2014, to discuss the role of stem cell transplantation (SCT) in the treatment of multiple myeloma and other plasma cell disorders. Scientists and clinicians working in the field gathered to discuss a variety of topics including the results of recent clinical trials, basic research, the concept of minimal residual disease, and immune modulation. As individual presentations revealed, important advances have occurred in our understanding of the pathophysiology of myeloma and the role that SCT, along with other forms of immunotherapy, plays in treating it. Each presentation stimulated discussion and exchange of ideas among the attendants. We decided to summarize and, importantly, to update the meeting proceedings in this review to share stimulating discussions and ideas on potentially novel treatment strategies among clinicians.

AB - The European Society for Blood and Marrow Transplantation Chronic Malignancies Working Party held a preceptorship meeting in Turin, Italy on 25-26 September 2014, to discuss the role of stem cell transplantation (SCT) in the treatment of multiple myeloma and other plasma cell disorders. Scientists and clinicians working in the field gathered to discuss a variety of topics including the results of recent clinical trials, basic research, the concept of minimal residual disease, and immune modulation. As individual presentations revealed, important advances have occurred in our understanding of the pathophysiology of myeloma and the role that SCT, along with other forms of immunotherapy, plays in treating it. Each presentation stimulated discussion and exchange of ideas among the attendants. We decided to summarize and, importantly, to update the meeting proceedings in this review to share stimulating discussions and ideas on potentially novel treatment strategies among clinicians.

U2 - 10.3109/10428194.2015.1131278

DO - 10.3109/10428194.2015.1131278

M3 - SCORING: Journal article

C2 - 26735310

VL - 57

SP - 1256

EP - 1268

JO - LEUKEMIA LYMPHOMA

JF - LEUKEMIA LYMPHOMA

SN - 1042-8194

IS - 6

ER -